Celanese Corporation (NYSE:CE) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Celanese CFO to take temporary medical leave of absence
On October 23, 2017, Celanese Corporation (the “Company”) announced that Executive Vice President and Chief Financial Officer Christopher W. Jensen will be on a temporary medical leave of absence, effectively immediately. In Mr. Jensen’s absence, other executive officers will assume many of Mr. Jensen’s duties while remaining in their current positions. In particular, Kevin S. Oliver, the Company’s Chief Accounting Officer (principal accounting officer) since July 2016 and Controller since May 2012, will act as the Company’s principal financial officer and assume responsibility for finance, tax and treasury.
About Celanese Corporation (NYSE:CE)
Celanese Corporation (Celanese) is a technology and specialty materials company. The Company operates through four segments: Advanced Engineered Materials, Consumer Specialties, Industrial Specialties and Acetyl Intermediates. Its business involves processing chemical raw materials, such as methanol, carbon monoxide, ethylene and natural products, including wood pulp, into chemicals, thermoplastic polymers and other chemical-based products. It engineers and manufactures a range of products, which serves a range of end-use applications, including paints and coatings, textiles, automotive applications, consumer and medical applications, performance industrial applications, filtration applications, paper and packaging, chemical additives, construction, consumer and industrial adhesives, and food and beverage applications. The Company operates in North America, Europe and Asia and consists of approximately 20 global production facilities.
An ad to help with our costs